TRPC6 and B-cell non-Hodgkin lymphoma: Moreover, lovastatin, a statin that is able to reduce cancer incidence and mortality [110,111,112,113], has been found to inhibit human Daudi B cell lymphoma proliferation by reducing membrane cholesterol, intracellular ROS, and TRPC6 expression and activity, suggesting a contribution of this Ca2+ -permeable channel in lymphoma proliferation [53].